Understanding how Fgf8 affects jaw size and symmetry

Molecular and cellular mechanisms underlying Fgf8-dosage mediated defects in jaw size and symmetry

NIH-funded research University of Massachusetts Lowell · NIH-10875804

This study looks at how a signaling factor called Fgf8 affects jaw development, which could help us understand why some people have jaw-related birth defects, ultimately aiming to improve treatments for those conditions.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Lowell NIH-funded
Lab location1 site (Lowell, United States)
Project IDNIH-10875804 on NIH RePORTER

What this research studies

This research investigates the molecular and cellular mechanisms that influence jaw development, particularly focusing on the role of the Fgf8 signaling factor. By examining how Fgf8 dosage impacts the growth and symmetry of the jaw skeleton, the study aims to uncover the underlying causes of craniofacial malformations. The approach involves analyzing the development of specific structures in the pharyngeal arches, which are crucial for proper jaw formation. Patients may benefit from insights gained into how these developmental processes can lead to birth defects.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with craniofacial malformations, particularly those associated with conditions like 22q11 deletion syndrome.

Not a fit: Patients without craniofacial malformations or those not affected by related genetic syndromes may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and potential interventions for craniofacial malformations in affected patients.

How similar studies have performed: Previous research has shown promising results in understanding craniofacial development, indicating that this approach may yield valuable insights.

Where this research is happening

Lowell, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions 22q11 Chromosomal Microdeletion Syndrome22q11 Deletion Syndrome22q11.2 deletion syndromeAutosomal dominant Opitz G/BBB syndromeCHARGE syndrome
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.